This table shows the association of HER2/neu expression with other clinicopathological features such as gender, age, CEA levels, histology, colonoscopic findings, histological grade, tumor site, tumor stage, lymph node status, lymphovascular invasion, and depth of tumor invasion with HER2/neu positivity. This evidence concerns the gene CEACAM5 and neoplasm.